Friday, August 11, 2017 7:08:27 AM
As for PP or a j/v. They will need Money to continue. but this time they have results to back them up with. Any dip should be short lived imho. if they can find a big partner, I will be happy. They pay for us. If that happens or not remains to be seen.
The last 3 months of the year will be crucial. We will have a six month update on the first 3 and a 3 month update on the remaining 6 patients of the second group. We should also, if we are lucky, get information on other cancers, such as GBM and maybe prostate.
Lots of things happening. I suspect an announcement that they will enter Phase 2 studies could propel us much higher. Now just let's hope the results are as good going forward with no recurrence. Otherwise, well, down we go. But so far, most shareholders are very happty with results. Not so much with share price, so maybe something is holding it down. We will see what happens when results drop in. Media attention could do wonders if it were to occur.
There are those who understand this much better than I do, so better check with them as well. i suggest the Stockhouse board for more info.
Best regards
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM